How to Source Naproxen 220 mg tablets for Pharmaceutical Formulation
Naproxen 220 mg tablets (Tablets, 250 mg, 375 mg, 500 mg, 550 mg) is classified under Arthritis. It is therapeutically aligned with reference brands such as Aleve(US); Naprosyn(EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Naproxen 220 mg tablets for formulation, R&D, or bulk manufacturing.
Product Overview:
Naproxen inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis, which alleviates pain, inflammation, and fever. Benefits include effective relief of arthritis pain, menstrual cramps, and acute injuries. It offers long-lasting anti-inflammatory effects, making it ideal for chronic conditions with a reliable safety profile when used appropriately.
Naproxen tablets are approved in the EU and US for pain, inflammation, and rheumatoid arthritis. In...
Naproxen 220 mg tablets API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Naproxen 220 mg tablets must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Naproxen 220 mg tablets is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Naproxen 220 mg tablets is more than procurement—it’s a strategic partnership. With its tablets form and 250 mg, 375 mg, 500 mg, 550 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Naproxen 220 mg tablets.
Request a Quote
Frequently Asked Questions For Sourcing of Naproxen 220 mg tablets
What is the typical lead time for Naproxen 220 mg tablets?
Lead times range from 4–6 weeks depending on supplier and region.
Is Naproxen 220 mg tablets available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Naproxen 220 mg tablets require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Naproxen 220 mg tablets?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Naproxen 220 mg tablets?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Naproxen 220 mg tablets?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Naproxen 220 mg tablets suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Naproxen 220 mg tablets be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.